Medicare Enrolled

Dr. Sejal Kuthiala, MD

Hematology & Oncology · Jacksonville, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
7015 A C SKINNER PKWY STE 1, Jacksonville, FL 32256
9047397779
In practice since 2006 (19 years)
NPI: 1093752826 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kuthiala from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kuthiala? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kuthiala

Dr. Sejal Kuthiala is a hematology & oncology in Jacksonville, FL, with 19 years in practice. Based on federal Medicare data, Dr. Kuthiala performed 49,294 Medicare services across 1,752 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kuthiala received a total of $1,031 from 29 pharmaceutical and/or device companies across 50 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kuthiala is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 17% volume in FL$ $1,031 industry payments

Medicare Practice Summary

Medicare Utilization ↗
49,294
Medicare services
Top 17% in FL for hematology & oncology
1,752
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,594 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Iron infusion (Injectafer)28,500$1$4
Epoetin alfa injection (Retacrit) for anemia7,240$6$27
Darbepoetin injection (Aranesp) for anemia2,900$2$14
Denosumab injection (Prolia/Xgeva)2,460$18$43
Contrast dye for imaging (iodine-based)1,500$0$1
Complete blood count (CBC) with differential1,104$8$41
Dexamethasone injection (steroid)1,100$0$1
Blood draw (venipuncture)1,057$8$18
Anti-nausea injection (Aloxi/palonosetron)650$1$75
Office visit, established patient (20-29 min)529$63$104
Drug injection, under skin or into muscle528$10$42
Office visit, established patient (30-39 min)357$94$162
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less337$21$90
Administration of chemotherapy into vein, 1 hour or less183$93$355
Hospital follow-up visit, moderate complexity118$63$115
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less113$46$160
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg107$1$7
Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services86$73$70
Injection of additional new drug or substance into vein56$11$55
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour50$16$55
Administration of chemotherapy into vein, each additional hour38$20$80
Infusion, normal saline solution , 1000 cc38$2$97
Initial hospital admission, moderate complexity37$103$225
Injection, diphenhydramine hcl, up to 50 mg34$1$4
Infusion into a vein for hydration, 31-60 minutes28$24$130
Infusion into a vein for hydration, each additional hour26$10$40
New patient office visit (45-59 min)23$123$265
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries16$376$1,000
Ct scan of chest with contrast14$51$500
Nuclear medicine study from skull base to mid-thigh with ct scan14$1,021$2,400
New patient office visit (30-44 min)14$83$181
Initial hospital admission, high complexity13$137$330
CT scan of abdomen and pelvis with contrast12$174$535
Blood creatinine level12$5$29
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
59.0% high complexity
34.2% medium
6.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$1,031
Total received (2018-2024)
Avg $147/year across 7 years
Bottom 29% in FL for hematology & oncology
29
Companies
50
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$923 (89.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$108 (10.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$181
2023
$240
2022
$78
2021
$107
2020
$70
2019
$280
2018
$75

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Foundation Medicine, Inc.
$142
Medtronic, Inc.
$135
Exelixis Inc.
$96
Novartis Pharmaceuticals Corporation
$91
GlaxoSmithKline, LLC.
$54
Merck Sharp & Dohme Corporation
$50
PFIZER INC.
$50
Genentech USA, Inc.
$32
Alexion Pharmaceuticals, Inc.
$32
Alnylam Pharmaceuticals Inc.
$32
Janssen Biotech, Inc.
$31
Takeda Pharmaceuticals U.S.A., Inc.
$29
Immunocore Limited
$24
Incyte Corporation
$24
Daiichi Sankyo Inc.
$19
EISAI INC.
$18
Innate Pharma, Inc
$16
Astellas Pharma US Inc
$15
ABBVIE INC.
$14
Bayer Healthcare Pharmaceuticals Inc.
$14
Aurobindo Pharma USA, Inc.
$14
TAIHO ONCOLOGY, INC.
$14
SERVIER PHARMACEUTICALS LLC
$14
SpringWorks Therapeutics, Inc.
$13
MEDIVATION FIELD SOLUTIONS LLC
$13
Gilead Sciences, Inc.
$12
Global Blood Therapeutics, Inc.
$12
Eisai Inc.
$12
Secura Bio, Inc.
$9
Top 3 companies account for 36.2% of total payments
Associated products mentioned in payments ›
ALUNBRIG · Cabometyx · DARZALEX · Enhertu · FEMARA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Farydak · Folotyn · GIVLAARI · INLYTA · JAKAFI · KEYTRUDA · KIMMTRAK · Kadcyla · LONSURF · Lenvima · Lumoxiti · MEKINIST · Nubeqa · OGSIVEO · OXBRYTA · SCEMBLIX · SHINGRIX · SYNCHROMEDII · TASIGNA · TECENTRIQ · Tibsovo · ULTOMIRIS · VENCLEXTA · XOSPATA · XTANDI · ZEJULA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (90%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $2 per 100 Medicare services performed
Looking for a hematology & oncology in Jacksonville?
Compare hematology & oncologys in the Jacksonville area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncologys nearby

Geographic Context

Hematology & Oncologys within 10 mi
103
Per 100K population
10.2
County median income
$68,447
Nearest hospital
MAYO CLINIC
5.7 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Kuthiala is a mixed practice specialist, with above-average Medicare volume (top 17% in FL), and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Kuthiala experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Kuthiala performed 28,500 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kuthiala receive payments from pharmaceutical companies?
Yes. Dr. Kuthiala received a total of $1,031 from 29 companies across 50 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kuthiala's costs compare to other hematology & oncologys in Jacksonville?
Dr. Kuthiala's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kuthiala) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →